Demonstrates a semi-supervised learning method for prostate cancer classification, suggesting effective use even with limited labeled data.
Prostate cancer is diagnosed through a comprehensive study of histopathology slides, which takes time and requires professional interpretation. To minimize this load, we developed a semi-supervised learning technique that combines transformer-based representation learning and a custom TransUNet classifier. To capture a wide range of morphological structures without manual annotation, our method pretrains DINOv2 on 10,000 unlabeled prostate tissue patches. After receiving the transformer-derived features, a bespoke CNN-based decoder uses residual upsampling and carefully constructed skip connections to merge data from many spatial scales. Expert pathologists identified only 20% of the patches in the whole dataset; the remaining unlabeled samples were contributed by using a consistency-driven learning method that promoted reliable predictions across various augmentations. The model received precision and recall scores of 91.81% and 89.02%, respectively, and an accuracy of 93.78% on an additional test set. These results exceed the performance of a conventional U-Net and a baseline encoder–decoder network. All things considered, the localized CNN (Convolutional Neural Network) decoding and global transformer attention provide a reliable method for prostate cancer classification in situations with little annotated data.
No takes yet. Share an insight, caveat, or question.
Rabeya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: